Tau pathology in Alzheimer disease and other tauopathies

Iqbal, Khalid, del C. Alonso, Alejandra, Chen, She, Chohan, M. Omar, El-Akkad, Ezzat, Gong, Cheng-Xin, Khatoon, Sabiha, Li, Bin, Liu, Fei, Rahman, Abdur, Tanimukai, Hitoshi, Grundke-Iqbal, Inge·2005·Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
DOI 10.1016/j.bbadis.2004.09.008

Cited by (999)

Items 901–999 of 999

  1. Terapia de los Sentidos como Tratamiento de la Agitación en Pacientes con la Enfermedad de Alzheimer
    Rueda Ordóñez, Carlos Joaquín · 2013 · USFQ Digital Repository (Universidad San Francisco de Quito)
  2. Pseudophosphorylation of tau modulates its function and induces AD-like changes
    Qian Sun · 2009 · KU ScholarWorks (The University of Kansas)
  3. IN VIVO RAT MODELS OF BRAIN -AMYLOID
    Eszter Sipos · 2009
  4. The role of mTor in the pathogenesis of tau-related pathologies in Alzheimer Disease
    Zhi Tang · 2014 · Figshare
  5. INTRACELLULAR DYNAMICS OF ALZHEIMER DISEASE-RELATED PROTEINS
    Alexandra V. Selivanova · 2007 · Figshare
  6. A bayesian translational framework for knowledge propagation, discovery, and integration under specific contexts.
    Michelle Rui Deng, Amin Zollanvari, Gil Alterovitz · 2012 · Europe PMC (PubMed Central)
  7. DEVELOPMENT OF A LIVE-CELL ASSAY PLATFORM TO STUDY PROTEIN-PROTEIN INTERACTIONS OF MICROTUBULE-ASSOCIATED PROTEIN TAU
    Niko-Petteri Nykänen · 2012 · UEF eRepo (University of Eastern Finland)
  8. A KRÓNIKUS AGYI HIPOPERFÚZIÓ SZEREPE AZ ALZHEIMER-KÓR KIALAKULÁSÁBAN
    Dénes Zádori, Datki Zsolt, Botond Penke, Zsolt Datki · 2007
  9. Multipotent neural stem/progenitor cells as a model of genetic neuronal diseases
    Virve Kärkkäinen · 2012 · UEF eRepo (University of Eastern Finland)
  10. SilencingofCDK5ReducesNeurofibrillaryTanglesin TransgenicAlzheimer'sMice
    Bangalore S Manjunath · 2010
  11. RetinoicAcidAttenuates-AmyloidDepositionandRescues MemoryDeficitsinanAlzheimer'sDiseaseTransgenic MouseModel
    J. ShawnGoodwin · 2008
  12. Aβ Conformation Dependent Antibodies and Alzheimer's Disease
    Dag Sehlin · 2010 · KTH Publication Database DiVA (KTH Royal Institute of Technology)
  13. COMPUTERIZED TOOLS: A SUBSTITUTE OR A SUPPLEMENT WHEN DIAGNOSING ALZHEIMER'S DISEASE?
    Aguilar Palomeque, Carlos Alberto · 2015 · Figshare
  14. Dietary regulation of PI3K/AKT/GSK-3β pathway in
    Yasuko Kitagishi, Atsuko Nakanishi, Yasunori Ogura, Satoru Matsuda · 2014
  15. ANALISIS DE POLIMORFISMOS DE GENES RELACIONADOS CON LA FUNCION ENDOTELIAL Y LA MUERTE CELULAR EN DEMENCIA VASCULAR Y
    Facultad De Medicina · 2013
  16. 14 Alzheimer's Dementia
    Seema Gulyani, Mark P. Mattson · 2010
  17. Cerebral white matter changes : Differentiating vascular and degenerative cognitive impairment
    Vidar Tveit Vasfaret Stenset · 2009 · NORA - Norwegian Open Research Archives
  18. Alzheimer’s Disease—is it Caused by Cerebrovascular Dysfunction?
    Christian Humpel · 2009 · Oxford University Press eBooks
  19. Emerging Principles and Biomarkers in In Vitro Diagnostics for Alzheimer's Disease
    Renee D. Wegrzyn · 2012 · Frontiers in neuroscience
  20. Why the Negative Studies in Alzheimer’s Disease?
    Hans Jörg Möbius · 2013 · Elsevier eBooks
  21. Alzheimer’s Disease Today
    Michael R. D’Andrea · 2015 · Elsevier eBooks
  22. Nek6 controls mitotic progression through regulating EML3 localisation to spindle microtubules
    Jessica M. Montgomery · 2016 · Figshare
  23. Quantitative analysis of neuropathological alterations in two transgenic mouse models of Alzheimer's disease
    Anastasiia Kurdakova · 2016 · eDiss (Georg-August-Universität Göttingen)
  24. Alzheimer’s Dementia
    Seema Gulyani, Mark P. Mattson · 2009 · Humana Press eBooks
  25. Endocrine and diagnostic aspects of cognitive impairment with special reference to Alzheimer’s disease
    Per Johansson · 2013 · Lund University Publications (Lund University)
  26. Identifying the mechanism of Aβ42 inhibition of PDGF-BB signalling
    Golam T. Saffi · 2014 · UWSpace (University of Waterloo)
  27. In Vitro and In Vivo Studies on Antibodies - N-terminally Truncated Abeta in the 5XFAD Mouse Model
    Bernhard Clemens Richard · 2015 · eDiss (Georg-August-Universität Göttingen)
  28. Amyloid-β and lysozyme proteotoxicity in Drosophila : Beneficial effects of lysozyme and serum amyloid P component in models of Alzheimer’s disease and lysozyme amyloidosis
    Liza Bergkvist · 2017 · Linköping studies in science and technology. Dissertations
  29. Molecular Aspects of Concussion and Chronic Traumatic Encephalopathy
    A. A. Farooqui · 2018 · Elsevier eBooks
  30. Neuro-pathological Implications of β-Amyloid Protein: An Update
    Nancy Maurya, Nupur Rani Agarwal · 2018 · Proceedings of the Nature Research Society
  31. Magnetic resonance imaging and spectroscopy in at-risk populations and preclinical Alzheimer's disease
    Olga Voevodskaya · 2018 · Figshare
  32. Analyse neurodegenerativer Prozesse im Gyrus Dentatus im Tg4-42-Mausmodell der Alzheimerdemenz
    Nils L. Schubert · 2018
  33. Análise de biomarcadores e déficit comportamental associados à doença de Alzheimer em um modelo animal de predisposição genética à epilepsia
    Israel C. Vasconcelos · 2018 · Digital Library of Theses and Dissertations (Universidade de São Paulo)
  34. Synthesis and characterization of fluorescent stilbene-based probes targeting amyloid fibrils
    Jun Zhang · 2018 · Linköping studies in science and technology. Dissertations
  35. MOLECULAR DOCKING STUDIES OF SOME N-AMIDOALKYLATED DERIVATIVES OF 2-AMINO-1,3,4-OXADIAZOLE AS POTENTIAL INHIBITORS OF GLYCOGEN SYNTHASE KINASE-3β
    Pavlo V. Zadorozhnii, Ihor O. Pokotylo · 2018 · Technology transfer innovative solutions in medicine
  36. Chemical structures and biological activities of anti-AD natural products
    Jun Wang, Xian‐Hua Meng, Weifeng Wang, Xiao-Bo Zhao, Caihong Li, Junli Yang, Yan‐Ping Shi · 2018 · Scientia Sinica Chimica
  37. ANALYSIS OF ATP-DEPENDENT CHAPERONE PROTEIN INTERACTIONS WITH MISFOLDED PROTEINS, AMYLOIDS, AND AGGREGATED PROTEINS
    Shannon E. May · 2018
  38. Screening and evaluation of natural compounds for therapeutic application in Alzheimer's disease
    Somashekara Nirvanashetty · 2024 · Swinburne figshare (Swinburne University of Technology)
  39. Базисная терапия болезни Альцгеймера: современные тенденции
    Редакция «Украинского медицинского журнала», Alla Osadchy · 2019 · Український медичний часопис
  40. Effects of Aβ42 on the human proteome and compound library screening using cellular models of Alzheimer's disease
    Swananda Modak · 2013 · Research Explorer (The University of Manchester)
  41. Investigation into the molecular complexity of Alzheimer's disease : an amyloid-β centered approach
    Federica Cioffi · 2019
  42. Bio-adhesion and cleanliness in bio-processing
    Palmer, Jonathan · 2017 · Spiral (Imperial College London)
  43. Effect of Aqueous Extract of Lavandula Angustifolia on Clearance of Amyloid Beta Plaques
    Masoud Soheili Kashani, Mahmoud Salami, m rezaee tavirani, kafashian · 2013 · journal of ilam university of medical sciences
  44. Detection of Alzheimer's Disease at Mild Cognitive Impairment Stage using EEG Signals
    Aarti Sharma, Jaynendra Kumar Rai, Ravi Prakash Tewari · 2019 · IEEE Uttar Pradesh Section International Conference on Electrical, Electronics and Computer Engineering (UPCON)
  45. Diagnosis and Treatment of Alzheimer’s Disease in Elderly and Senile Age
    V S Myakotnykh · 2019 · Advances in Gerontology
  46. Photo-excited Toluidine Blue disaggregates the Repeat Tau and modulates cytoskeletal structure in neuronal cells
    Tushar Dubey, Nalini Vijay Gorantla, Subashchandrabose Chinnathambi · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  47. Alzheimer's Disease: Parsing the Pathways Leading to the Disease Based on the Spirochete/Biofilm Hypothesis
    Herbert B. Allen · 2020 · OBM Geriatrics
  48. A GLANCE ON STRUCTURE AND ABNORMAL HYPERPHOSPHORYLATION OF TAU PROTEIN
    shaik salma, Dondapati Snehitha, Dabbeeru Gayathri, Yeminedi Sainadh · 2020 · Journal of Emerging Technologies and Innovative Research
  49. Perinatal Programming - New Insights into the Origins of Neurodegenerative Disorders.
    A Tarkowska, a Furmaga-Jab o ska · 2020 · Current Pediatric Research
  50. Genetic and functional studies of genes involved in the pathogenesis of Alzheimer's disease
    Teemu Natunen · 2014 · UEF eRepo (University of Eastern Finland)
  51. Factors Related to Alzheimer’s Disease, Tau Pathology in Alzheimer’s Disease: Possible Treatments for Tau Pathology
    Yethindra Vityala · 2020 · Indian Journal of Forensic Medicine & Toxicology
  52. A failure of β-amyloid physiological function due to genetic deletion of α7 nicotinic acetylcholine receptors induces an Alzheimer’s disease-like pathology
    Maria Rosaria Tropea, Domenica Donatella Li Puma, Marcello Melone, Walter Gulisano, Ottavio Arancio, Claudio Grassi, Fiorenzo Conti, Daniela Puzzo · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  53. Disorders of cognitive activity in patients with multiple sclerosis and hepatocerebral degeneration and its prevention
    Ivan Voloshyn-Gaponov, I. V. Lantukh, Петро Гапонов · 2020 · Reports of Vinnytsia National Medical University
  54. Análise da biogênese e disfunção mitocondrial na progressão da doença de Alzheimer em camundongos 3xTg-AD.
    Monique Patrício Singulani · 2020 · Digital Library of Theses and Dissertations (Universidade de São Paulo)
  55. Biomedicine & Diseases: Review RNA and protein-dependent mechanisms in tauopathies: consequences for therapeutic strategies
    Jean‐Marc Gallo, Wendy J. Noble, T. Rodriguez Martin · 2007
  56. Psychiatric Disorders in Dementia
    Yannick Vermeiren, Debby Van Dam, Maartje de Vries, Peter Paul De Deyn · 2020 · Springer eBooks
  57. Molecular insights into the Tau-actin interaction
    Yunior Cabrales Fontela · 2018 · eDiss (Georg-August-Universität Göttingen)
  58. Principles of Pharmacology in Dementia
    Francisco Assis Carvalho Vale, Judith Thomas Tayra, Carina Tellaroli Spedo · 2022 · Springer eBooks
  59. MicroRNAs as Future Treatment Tools and Diagnostic Biomarkers in Alzheimer’s Disease
    Heena Chauhan, Pawan Kumar Gupta, Bhagawati Saxena · 2022 · IntechOpen eBooks
  60. Dementing brain processes in patients with Wilson’s disease and multiple sclerosis (pathogenesis and treatment approaches)
    Voloshyn-Gaponov Ivan K., Петро Костянтинович Гапонов · 2019 · Psychiatry Neurology and Medical Psychology
  61. Alzheimer’s Disease
    Chad Hales, Allan I. Levey · 2011
  62. Dementia
    Christopher I. Wright, Nhi‐Ha Trinh, Deborah Blacker, William E. Falk · 2008 · Elsevier eBooks
  63. Tauopathy
    Suzanne Musil · 2018 · Springer eBooks
  64. Alzheimer’s Disease
    Shrikaanth Krishnamurthy · 2019 · Cambridge University Press eBooks
  65. Photo-excited Toluidine Blue Disaggregates the Repeat Tau and Modulates End-binding Protein EB1, Cytoskeletal Structure in Neuronal Cells
    Tushar Dubey, Nalini Vijay Gorantla, Subashchandrabose Chinnathambi · 2020 · Research Square
  66. Regulation of gene expression over cycles of torpor-arousal in thirteen-lined ground squirrels
    Shannon N. Tessier · 2014 · Carleton University's Institutional Repository (MacOdrum Library, Carleton University)
  67. Tauopathy
    Suzanne Musil · 2010 · Springer eBooks
  68. Tauopathy
    Suzanne Musil · 2018 · Springer eBooks
  69. Alzheimer’s disease
    Brandy R. Matthews · 2016 · Cambridge University Press eBooks
  70. Risk Factors and Current Understanding of Alzheimers Disease
    Neetu Saini · 2018 · Research Journal of Life Sciences Bioinformatics Pharmaceutical and Chemical Sciences
  71. Correction: Analyzing Gene Expression from Whole Tissue vs. Different Cell Types Reveals the Central Role of Neurons in Predicting Severity of Alzheimer’s Disease
    Shiri Stempler, Eytan Ruppin · 2012 · PLoS ONE
  72. Faculty Opinions recommendation of NLRP3 inflammasome activation drives tau pathology.
    Jeffrey Skolnick · 2019 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  73. Intensive protein synthesis in neurons and phosphorylation of beta-amyloid precursor protein and tau-protein are triggering factors of neuronal amyloidosis and Alzheimer’s disease
    Alexander V. Maltsev, Nikita V. Dovidchenko, Victor Konstantinovich Uteshev, Viktoriya V. Sokolik, O. M. Shtang, M. A. Yakushin, N. M. Sokolova, Alexey K. Surin, Oxana V. Galzitskaya · 2013 · Biochemistry (Moscow) Supplement Series B Biomedical Chemistry
  74. Safety, tolerability, and pharmacokinetics of fluoropezil (DC20), a novel AChE inhibitor: a single-center, phase I study in healthy young and elderly Chinese subjects
    Hongjie Qian, Chengyin Yu, Huijuan Zhu, Qichen Ding, Yuting Cai, Jiao Jing, Xin Ping Xu, Runcong Guo, Haiyan Zhang, Hong Shu Liu et al. · 2022 · Research Square
  75. Cannabinoid-basierte Therapie in einem Modell für die sporadische Alzheimer-Erkrankung
    Marius E. Sichler · 2022 · eDiss (Georg-August-Universität Göttingen)
  76. Faecal microbiota transplantation from Alzheimer’s participants induces impairments in hippocampal neurogenesis and cognitive behaviours in rats
    Stefanie Grabrucker, Moira Marizzoni, Edina Silajdžić, Nicolo Lopizzo, Elisa Mombelli, Sarah Nicolas, Sebastian Dohm-Hansen, Catia Scassellati, Davide Vito Moretti, Melissa Rosa et al. · 2022 · Research Square
  77. Adipokines and Alzheimer's Disease
    Maria Angela Sortino, Sara Merlo, Simona Federica Spampinato · 2011 · Royal Society of Chemistry eBooks
  78. Causal Inference with Secondary Outcomes
    Ying Zhou, Alzheimer’s Disease Neuroimaging Initiative · 2023 · Statistics in Biosciences
  79. Peer Review #3 of "Regulation of LncRNAs and microRNAs in neuronal development and disease (v0.3)"
    2023 · PeerJ
  80. Peer Review #1 of "Regulation of LncRNAs and microRNAs in neuronal development and disease (v0.1)"
    2023 · PeerJ
  81. Peer Review #1 of "Regulation of LncRNAs and microRNAs in neuronal development and disease (v0.3)"
    2023 · PeerJ
  82. Peer Review #3 of "Regulation of LncRNAs and microRNAs in neuronal development and disease (v0.1)"
    2023 · PeerJ
  83. Peer Review #2 of "Regulation of LncRNAs and microRNAs in neuronal development and disease (v0.1)"
    2023 · PeerJ
  84. Peer Review #2 of "Regulation of LncRNAs and microRNAs in neuronal development and disease (v0.3)"
    2023 · PeerJ
  85. Pharmacological Treatment of Cognitive and Behavioral Disorders in Dementia
    Fabiana Mirella Trotta, Leonardo Biscetti, Antonio Cherubini · 2023 · Practical issues in geriatrics
  86. ผลการปกปองของสารสกดใบรางจดจากการเหนยวนำความเปนพษดวยกลตาเมตในเซลลประสาท HT-22 ผานวถออโตฟาจ
    วุฒิพงษ์ วงศ์ทิพย์ · 2019
  87. Effects and mechanisms of caesalpinia mimosoides leaf extract on oxidative stress resistance and anti-aging activity in caenorhabditis elegans and neurite outgrowth activity in neuro2a cells
    Panthakarn Rangsinth · 2019
  88. Fat and Alzheimer’s Disease
    Suset Rodriguez, Ramakrishnan Thiruchelvi, Arokiasamy Justin Thenmozhi, Daniela S. Cosio, Nagarajarao Shamaladevi, Hussain Hussain, Sampath Natarajan, Michael John Paidas, Arumugam Radhakrishnan Jayakumar · 2023 · Nutritional neurosciences
  89. Calciopathies and Neuropsychiatric Disorders: Physiological and Genetic Aspects
    Natalia A. Dyuzhikova, M. B. Pavlova · 2023 · Neuroscience and Behavioral Physiology
  90. Induced-pluripotent stem cells and neuroproteomics as tools for studying neurodegeneration
    Caroline Brandão‐Teles, Giuliana S. Zuccoli, Talita Aparecida de Moraes Vrechi, Lívia Ramos-da-Silva, Aline Valéria Sousa Santos, Fernanda Crunfli, Daniel Martins‐de‐Souza · 2024 · Biochemical Society Transactions
  91. Polycyclitol derivatives restore long-term memory by regulating cdk5/p25 based tau signaling in experimental cerebral malaria
    Praveen Kumar Simhadri, Showkat Rashid, Shailaja Karri, Bilal A. Bhat, Phanithi Prakash Babu, Goverdhan Mehta · 2024
  92. Calciopathies and Neuropsychic Disorders: Physiological and Genetic Aspects
    Natalia A. Dyuzhikova, M. B. Pavlova · 2023 · Успехи физиологических наук
  93. Güncel Biyokimya Çalışmaları VII
    Yasemin Atıcı, Zeynep Ökten, Sara Kasebi, Buse Semerci Arıkan, Mehmet Erdem, Tuğba Raika Kıran, Abdullah Kaan Yağız, Berat Aktolun, Yeşim Güvenç Demirağcı, Hatibe Kara et al. · 2024 · Akademisyen Kitabevi eBooks
  94. Neurocognitive Disorders and Dementia
    Marc Weinberg, Sun Young Chung, Nhi‐Ha Trinh, Zeina N. Chemali, Jennifer R. Gatchel · 2024 · Elsevier eBooks
  95. Chromogranin A (CgA) Deficiency Attenuates Tauopathy by Altering Epinephrine–Alpha-Adrenergic Receptor Signaling
    Suborno Jati, Daniel Muñoz-Mayorga, Shandy Shahabi, Kechun Tang, Yuren Tao, Dennis W. Dickson, Irene Litvan, Gourisankar Ghosh, Sushil Kumar Mahata, Chen Xu · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  96. Histological Alterations Induced by Hypercholesterolemia Diet in Central Nervous System of Male Rats
    Hadeel Ganai Rafeash, Wefak Jbori Albazi, Muna Hussain Al-Aameli · 2024 · Egyptian Journal of Veterinary Science
  97. AD prevention strategies adapted till present
    Rayees Ahmad Naik, Mehak Naseer Mir, Roshni Rajpoot, S R Singh, Kusum Singh, Sandeep Kumar Singh · 2024 · Elsevier eBooks
  98. Pharmacotherapy of Neurocognitive Disorders and Dementia
    Marc S. Weinberg, Sun Young Chung, Nhi‐Ha Trinh, Zeina N. Chemali, Jennifer R. Gatchel · 2024 · Elsevier eBooks
  99. Alzheimer’s Disease: Hypotheses and therapies
    Nanyi Chen · 2025 · Theoretical and Natural Science